BLGTY News Alert Bio-Light Israeli (BLGTY) 3.9000 09/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bio-Light Israeli (BLGTY) 3.9000 $BLGTY

Merriman Capital Announces Sponsorship of BioLight Life Sciences Investments Ltd. on OTCQX
Thomson Reuters ONE - Tue Sep 23, 8:00AM CDT
SAN FRANCISCO - September 23, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will serve as the Principal American Liaison (PAL) for BioLight Life Sciences Investments Ltd. (OTCQX: BLGTY) ("BioLight" as it continues trading on OTCQX(R).

BioLight Announces First IOPtiMate(TM) System Sale in Hong Kong
PR Newswire - Wed Sep 10, 7:49AM CDT
BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate(TM) system in Hong Kong.

BioLight Announces Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
PR Newswire - Wed Jul 02, 8:23AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT) (OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the U.S. Patent and Trademark Office has issued patent number 8,765,166 covering the device that is inserted into the eye to treat an ocular condition that contains an active agent of a free acid salt form of a prostaglandin with a low elution rate profile that is contained in the long-term controlled-release insert platform. The patent will be in effect at least until May 2031. This patent covers the technology used in Eye-D®, the company's controlled-release latanoprost insert currently in a Phase 1/2a clinical study in the U.S. for the treatment of glaucoma.

BioLight Reports Successful Interim Results from Bladder Cancer Clinical Study
PR Newswire - Tue Jul 01, 4:23PM CDT
BioLight Life Sciences Investments Ltd. (OTC: BLGTY)(TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, achieved successful interim results in a blinded bladder cancer clinical trial with its CellDetect® technology. As a result, Micromedic will continue the trial with the goal of developing a kit for monitoring the recurrence of bladder cancer. This study is being conducted at seven medical centers and is expected to be completed in the fourth quarter of 2014.

First Patient Enrolled in FDA Phase 1/2a Clinical Trial With BioLight's Controlled-Release Latanoprost Insert for the Treatment of Glaucoma
PR Newswire - Mon Jun 30, 8:00AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D®, the company's controlled-release latanoprost insert for the treatment of glaucoma.

BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate(TM) for Glaucoma Surgery
PR Newswire - Thu Mar 06, 11:07AM CST
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the successful completion of an equity financing that raised gross proceeds of approximately NIS 19 million (USD 5.5 million).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Yellow River Basin Firms Focus on Global Expansion

Updated Category News Views 58

Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 73

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 114

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 141

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 110

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 25

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading

Top 5 Most Recently Viewed Articles

Renault Achieves 1.3% Sales Growth Amid Market Challenges

Updated Category News Views 325

Renault Reports Sales Growth of 1.3% in 2024 French automaker Renault has announced a modest yet significant sales increase of 1.3% for the year 2024. This growth is particularly noteworthy given the challenging automotive market conditions that have been witnessed globally. Renault’s performance in the fourth quarter was particularly strong, aided by new vehicle...

Continue Reading
Economy Insights: Charlie Munger’s Vision for Retail Market’s Future

Updated Category News Views 303

Understanding Munger's Predictions Charlie Munger, the legendary vice chairman of Berkshire Hathaway, offered profound insights into the evolving retail landscape long before changes became evident in store closures and consumer habits. His vision emphasized a decisive division between high-end luxury markets and budget-friendly retailers, leaving little room for...

Continue Reading
Market Reaction: Anticipation Builds for Jobs Data Release

Updated Category News Views 112

Market Overview and Futures Decline U.S. stock index futures have taken a hit, driven by expectations surrounding important jobs data that could greatly influence the Federal Reserve's upcoming decisions on interest rates. Investors are particularly focused on the forthcoming nonfarm payrolls report, which serves as a key indicator of economic health and is set to be...

Continue Reading
Forecasting AI Growth: A $237.4 Billion Market Expansion

Updated Category News Views 274

The Dynamic Growth of Artificial Intelligence Market The artificial intelligence (AI) market is on the verge of transformative growth, projected to expand by USD 237.4 billion from 2024 to 2028. This surge is anticipated as the market develops at a compound annual growth rate (CAGR) of 30.07% during the forecast period. AI's increasing implementation across various...

Continue Reading
ASP Isotopes Inc. Announces Major Public Stock Offering

Updated Category News Views 78

ASP Isotopes Inc. Launches Public Offering ASP Isotopes Inc. (NASDAQ:ASPI) has initiated a public offering of its common stock, aiming to bolster its operational capabilities. This development marks a significant step for the company as it continues to explore avenues for growth in the advanced materials sector. Details of the Public Offering The offering includes a...

Continue Reading